Norman Broadbent (NBB) Share Price, News & Analysis

Company Overview

Norman Broadbent is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally. Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

Key Stats

• Today's Range: 190 to 195
• 50-Day Range: 140 to 200
• 52-Week Range: 70 to 255.47
• Volume: 2,674 shs
• Average Volume: 4,508 shs
• Market Capitalization: £118.03 million
• P/E Ratio: 494.21
• Dividend Yield: 5.24%
• Price Target: N/A
• Consensus Rating: N/A

NBB Stock Analysis - Frequently Asked Questions

How have NBB shares performed this year?

Norman Broadbent's stock was trading at GBX 3.24 at the beginning of 2025. Since then, NBB shares have increased by 5,764.2% and is now trading at GBX 190.

How were Norman Broadbent's earnings last quarter?

Norman Broadbent plc (LON:NBB) posted its quarterly earnings results on Wednesday, April, 2nd. The company reported ($0.15) earnings per share (EPS) for the quarter. Norman Broadbent had a net margin of 2.02% and a trailing twelve-month return on equity of 16.52%.

How do I buy shares of Norman Broadbent?

Shares of NBB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Norman Broadbent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Norman Broadbent investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

• Last Earnings: 4/02/2025
• Today: 8/08/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Staffing & Employment Services
• Sub-Industry: N/A
• Current Symbol: LON:NBB
• CIK: N/A
• Web: www.normanbroadbent.com
• Phone: +44-20-74840000
• Fax: N/A
• Employees: 52
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 0.38
• Trailing P/E Ratio: 494.21
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £221.78 thousand
• Net Margins: 2.02%
• Pretax Margin: N/A
• Return on Equity: 16.52%
• Return on Assets: 3.92%

Debt

• Debt-to-Equity Ratio: 60.43
• Current Ratio: 0.98
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: £10.98 million
• Price / Sales: 10.75
• Cash Flow: GBX 5.07 per share
• Price / Cash Flow: 37.50
• Book Value: GBX 2.17 per share
• Price / Book: 87.62

Miscellaneous

• Outstanding Shares: 62,123,571
• Free Float: N/A
• Market Cap: £118.03 million
• Optionable: Not Optionable
• Beta: -0.10